Aprea Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Aprea Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aprea Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Aprea Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $14 | 3 | 4.67 |
2023-09-30 | $12 | 3 | 4.33 |
2023-06-30 | $9 | 3 | 3.00 |
2023-03-31 | $2.9k | 674 | 4.33 |